Cabozantinib S Malate

Showing Topics 1 - 6 of 6. RSS Feed

 Cabozantinib S Malate

Cabozantinib, sold under the brand-name Cabometyx and Cometriq, is a medication used to treat medullary thyroid cancer and a second line treatment for renal cell carcinoma among others. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. It was discovered and developed by Exelixis Inc. In 2012 cabozantinib in its capsule formulation was approved by the U.S. FDA under the name Cometriq for treating patients with medullary thyroid cancer.&a...
 NDC 42388-013
4 {21 (Cabozantinib 20 mg Oral Capsule [cometriq]) } Pack [cometriq 60 mg Daily Dose Carton] by Exelixis, Inc. ## Markings: XL184;20mg ## Shape: Capsule ## Color: Gray ## Package Codes: 42388-013-14 ## Active Ingredients: Cabozantinib S-malate
 NDC 42388-014
Cometriq 20 mg Oral Capsule by Exelixis, Inc. ## Markings: XL184;20mg ## Shape: Capsule ## Color: Gray ## Package Codes: 42388-014-25 ## Active Ingredients: Cabozantinib S-malate
 NDC 42388-024
Cabometyx 20 mg Oral Tablet by Exelixis, Inc. ## Markings: XL;20 ## Shape: Round ## Color: Yellow ## Package Codes: 42388-024-26 ## Active Ingredients: Cabozantinib S-malate
 NDC 42388-023
Cabometyx 60 mg Oral Tablet by Exelixis, Inc. ## Markings: XL;60 ## Shape: Oval ## Color: Yellow ## Package Codes: 42388-023-26, 42388-023-36 ## Active Ingredients: Cabozantinib S-malate
 NDC 42388-025
Cabometyx 40 mg Oral Tablet by Exelixis, Inc. ## Markings: XL;40 ## Shape: Triangle (3 sides) ## Color: Yellow ## Package Codes: 42388-025-26 ## Active Ingredients: Cabozantinib S-malate




Can't Find What You're Looking For? Submit a New Topic Below

No registration needed.
Simply fill out the form below.

 *
What are the main keywords of your topic?


 *

 *


 Optional, stays hidden.
Get notified when a reply is posted here.




5) Text Verification: *
Prevents SPAM.

Click here to show the question



This form will be submitted securely


TRUSTe

Discussion Thread Guidelines: Any participation in the discussion threads signifies your agreement with the Terms of Use and Privacy Policy. (1) Act civilized and be respectful towards others. No profanity, vulgarity or lewd / suggestive content is allowed. (2) Posts encouraging, facilitating, or seeking advice about the abuse of medications or other substances are prohibited. (3) Personal contact information (such as telephone numbers, email addresses, etc) is not allowed to appear on our discussion threads. (4) We do not allow our forums to be used for buying, selling, trading, or for the promotion of a product or service. (5) Posting external links to other web sites is not allowed without our prior approval. (6) We reserve the right to edit or remove content which we find objectionable to the community at our sole discretion.



Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA